zepzelcapro.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Metastatic SCLC Treatment | ZEPZELCA® (lurbinectedin) |
| Description | PURSUE A RESPONSE WITH ZEPZELCA® Discover ZEPZELCA, a treatment indicated for your metastatic SCLC patients with disease progression on or after platinum-based |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 67.227.159.235 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
zepzelcapro.com Valuation
|
US$13,409,344
Last updated: 2023-04-30 17:48:46
zepzelcapro.com has Semrush global rank of 789,323. zepzelcapro.com has an estimated worth of US$ 13,409,344, based on its estimated Ads revenue. zepzelcapro.com receives approximately 1,547,232 unique visitors each day. Its web server is located in United States, with IP address 67.227.159.235. According to SiteAdvisor, zepzelcapro.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$13,409,344 |
| Daily Ads Revenue | US$12,378 |
| Monthly Ads Revenue | US$371,336 |
| Yearly Ads Revenue | US$4,456,028 |
| Daily Unique Visitors | 103,149 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| zepzelcapro.com. | A | 14400 | IP: 67.227.159.235 |
| zepzelcapro.com. | NS | 14400 | NS Record: dns2.cscdns.net. |
| zepzelcapro.com. | NS | 14400 | NS Record: dns1.cscdns.net. |
| zepzelcapro.com. | MX | 14400 | MX Record: 10 custmx.cscdns.net. |
HtmlToTextCheckTime:2023-04-30 17:48:46
| Full Prescribing Information Important Safety Information This site is intended for US healthcare professionals only. This site is intended for US healthcare professionals only. Full Prescribing Information Important Safety Information Visit Patient Site Contact a Representative Clinical Data Clinical Data Study Design | ORR | Disease Control | Duration of Response | Safety Patient Subgroups Patient Subgroups Data Overview | Patient Identifier Dosing Dosing MOA MOA Recommendations NCCN Guidelines ® Patient Support & Resources Patient Support & Resources Patient Support & Reimbursement | Ordering | Resources | Videos | FAQ Visit Patient Site Contact a Representative For adults with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy, For adults with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy, PURSUE A RESPONSE WITH ZEPZELCA ® (lurbinectedin) EFFICACY SAFETY DOSING |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 11:26:11 GMT Server: Apache Location: https://zepzelcapro.com/ Cache-Control: max-age=600 Expires: Sat, 23 Oct 2021 11:36:11 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/2 301 location: https://www.zepzelcapro.com/ cache-control: max-age=600 expires: Sat, 23 Oct 2021 11:36:11 GMT content-type: text/html; charset=iso-8859-1 date: Sat, 23 Oct 2021 11:26:11 GMT server: Apache HTTP/2 200 last-modified: Tue, 11 May 2021 17:14:36 GMT accept-ranges: bytes content-length: 28976 cache-control: max-age=600 expires: Sat, 23 Oct 2021 11:36:11 GMT vary: Accept-Encoding,User-Agent content-type: text/html date: Sat, 23 Oct 2021 11:26:11 GMT server: Apache |
zepzelcapro.com Whois Information
Domain Name: ZEPZELCAPRO.COM Registry Domain ID: 2507483045_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-06-02T11:31:21Z Creation Date: 2020-03-25T18:56:03Z Registry Expiry Date: 2022-03-25T18:56:03Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T22:20:46Z <<< |